SanjayKulkarniMD

General Surgery • New Haven, CT

Transplantation

Associate Professor, Surgery, Yale University School of Medicine

Join to view full profile

Dr. Kulkarni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kulkarni's full profile

Already have an account?

Office
800 Howard Ave
Yale Physicians Building-3rd Floor
New Haven, CT 06519
Phone+1 203-785-2556

Fax+1 203-785-7162

Education & Training

University of ChicagoResidency, Surgery, 1995 - 2002
Medical College of WisconsinClass of 1995

Certifications & Licensure

CT State Medical License 2004 - 2025
IL State Medical License 1995 - 2005
American Board of Surgery Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow American College of Surgeons

Clinical Trials

Bariatric Surgery for ESRD Patients vs Control Start of enrollment: 2005 Oct 01
Terminated
Not Applicable
Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation Start of enrollment: 2011 Mar 01
Completed
Phase 1
Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Start of enrollment: 2013 Aug 01
Terminated
Phase 2
Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation Start of enrollment: 2021 Oct 01
Withdrawn
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

108 citations
KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Margaret J. Bia, Deborah Adey, Roy D. Bloom, L. Chan, Sanjay Kulkarni
American Journal of Kidney Diseases. 2010-08-01
107 citations
Alloantibody and Complement Promote T Cell–Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-κB Signaling in Endothelial Cells
Dan Jane-wit, Thomas D. Manes, Tai Yi, Lingfeng Qin, Pamela Clark
Circulation. 2013-12-03
19 citations
Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival
Xiaojia Guo, John C. Schmitz, Barton Kenney, Edward Uchio, Sanjay Kulkarni
Cancer Science. 2012-08-01

Press Mentions

Texas Surgeon Is Accused of Secretly Denying Liver TransplantsApril 17th, 2024